IS7157A - Útskiptar N-fenýl 2-hýdoxý-2-metýl-3,3,3-tríflúorprópanamíðafleiður sem auka virkni pýróvatvetnissviptis - Google Patents
Útskiptar N-fenýl 2-hýdoxý-2-metýl-3,3,3-tríflúorprópanamíðafleiður sem auka virkni pýróvatvetnissviptisInfo
- Publication number
- IS7157A IS7157A IS7157A IS7157A IS7157A IS 7157 A IS7157 A IS 7157A IS 7157 A IS7157 A IS 7157A IS 7157 A IS7157 A IS 7157A IS 7157 A IS7157 A IS 7157A
- Authority
- IS
- Iceland
- Prior art keywords
- pyruvate
- hydroxy
- phenyl
- methyl
- activity
- Prior art date
Links
- JHSBXNFXGVSVQO-UHFFFAOYSA-N 3,3,3-trifluoro-2-hydroxy-2-methyl-n-phenylpropanamide Chemical class FC(F)(F)C(O)(C)C(=O)NC1=CC=CC=C1 JHSBXNFXGVSVQO-UHFFFAOYSA-N 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 title 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 title 1
- 239000001257 hydrogen Substances 0.000 title 1
- 230000004060 metabolic process Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0120471.8A GB0120471D0 (en) | 2001-08-23 | 2001-08-23 | Chemical compounds |
| PCT/GB2002/003867 WO2003017995A1 (en) | 2001-08-23 | 2002-08-21 | Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluropropanamide derivatives which elevate pyruvate dehydrogenase activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS7157A true IS7157A (is) | 2004-02-19 |
Family
ID=9920849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7157A IS7157A (is) | 2001-08-23 | 2004-02-19 | Útskiptar N-fenýl 2-hýdoxý-2-metýl-3,3,3-tríflúorprópanamíðafleiður sem auka virkni pýróvatvetnissviptis |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20050026931A1 (is) |
| EP (1) | EP1425003A1 (is) |
| JP (1) | JP2005506976A (is) |
| KR (1) | KR20040030164A (is) |
| CN (2) | CN101328157A (is) |
| AR (1) | AR037497A1 (is) |
| AU (1) | AU2002321520B2 (is) |
| BR (1) | BR0212043A (is) |
| CA (1) | CA2458121A1 (is) |
| CO (1) | CO5560539A2 (is) |
| GB (1) | GB0120471D0 (is) |
| HU (1) | HUP0401149A2 (is) |
| IL (1) | IL160455A0 (is) |
| IS (1) | IS7157A (is) |
| MX (1) | MXPA04001552A (is) |
| NO (1) | NO326745B1 (is) |
| NZ (1) | NZ531261A (is) |
| PL (1) | PL368615A1 (is) |
| RU (1) | RU2301805C2 (is) |
| SA (1) | SA02230268B1 (is) |
| UA (1) | UA77967C2 (is) |
| WO (1) | WO2003017995A1 (is) |
| ZA (1) | ZA200401375B (is) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101108196B1 (ko) * | 2009-11-04 | 2012-01-31 | (주)유로파 | 쓰레기 자동 집하시설의 관로 전환기 |
| EP3022179B1 (en) * | 2013-07-18 | 2017-11-15 | Fondazione Istituto Italiano Di Tecnologia | Phenyl carbamates and their use as inhibitors of the fatty acid amide hydrolase (faah) enzyme and modulators of the d3 dopamine receptor (d3dr) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4537618A (en) * | 1982-05-26 | 1985-08-27 | Ciba Geigy Corporation | N-phenylsulfonyl-N'-pyrimidinylureas |
| GB9116069D0 (en) * | 1991-07-25 | 1991-09-11 | Ici Plc | Therapeutic amides |
| EP0539329A1 (de) * | 1991-10-25 | 1993-04-28 | Ciba-Geigy Ag | Acetylen-Verbindungen, verwendbar als Leukotrien-Antagonisten |
| GB9309716D0 (en) * | 1993-05-12 | 1993-06-23 | Zeneca Ltd | Heterocyclic derivatives |
| GB9310095D0 (en) * | 1993-05-17 | 1993-06-30 | Zeneca Ltd | Therapeutic compounds |
| GB9804648D0 (en) * | 1998-03-06 | 1998-04-29 | Zeneca Ltd | Chemical compounds |
| GB9805520D0 (en) * | 1998-03-17 | 1998-05-13 | Zeneca Ltd | Chemical compounds |
| GB9811427D0 (en) * | 1998-05-29 | 1998-07-22 | Zeneca Ltd | Chemical compounds |
| CZ2002773A3 (cs) * | 1999-09-04 | 2002-06-12 | Astrazeneca Ab | Substituované deriváty N-fenyl-2-hydroxy-2-methyl-3,3,3-trifluorpropanamidu, které zvyąují aktivitu pyruvátdehydrogenázy |
-
2001
- 2001-08-23 GB GBGB0120471.8A patent/GB0120471D0/en not_active Ceased
-
2002
- 2002-08-21 PL PL02368615A patent/PL368615A1/xx not_active Application Discontinuation
- 2002-08-21 HU HU0401149A patent/HUP0401149A2/hu unknown
- 2002-08-21 JP JP2003522515A patent/JP2005506976A/ja active Pending
- 2002-08-21 US US10/487,261 patent/US20050026931A1/en not_active Abandoned
- 2002-08-21 CN CNA2008101259041A patent/CN101328157A/zh active Pending
- 2002-08-21 UA UA2004032170A patent/UA77967C2/uk unknown
- 2002-08-21 EP EP02755224A patent/EP1425003A1/en not_active Withdrawn
- 2002-08-21 KR KR10-2004-7002620A patent/KR20040030164A/ko not_active Ceased
- 2002-08-21 CN CNA028207734A patent/CN1571665A/zh active Pending
- 2002-08-21 RU RU2004108466/04A patent/RU2301805C2/ru not_active IP Right Cessation
- 2002-08-21 NZ NZ531261A patent/NZ531261A/en unknown
- 2002-08-21 WO PCT/GB2002/003867 patent/WO2003017995A1/en not_active Ceased
- 2002-08-21 CA CA002458121A patent/CA2458121A1/en not_active Abandoned
- 2002-08-21 BR BR0212043-7A patent/BR0212043A/pt not_active IP Right Cessation
- 2002-08-21 AU AU2002321520A patent/AU2002321520B2/en not_active Ceased
- 2002-08-21 IL IL16045502A patent/IL160455A0/xx unknown
- 2002-08-21 MX MXPA04001552A patent/MXPA04001552A/es not_active Application Discontinuation
- 2002-08-23 AR ARP020103172A patent/AR037497A1/es unknown
- 2002-08-26 SA SA02230268A patent/SA02230268B1/ar unknown
-
2004
- 2004-02-19 ZA ZA200401375A patent/ZA200401375B/en unknown
- 2004-02-19 IS IS7157A patent/IS7157A/is unknown
- 2004-02-19 NO NO20040725A patent/NO326745B1/no not_active IP Right Cessation
- 2004-03-16 CO CO04024614A patent/CO5560539A2/es not_active Application Discontinuation
-
2006
- 2006-11-20 US US11/601,854 patent/US20070208032A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO326745B1 (no) | 2009-02-09 |
| UA77967C2 (en) | 2007-02-15 |
| NO20040725L (no) | 2004-02-19 |
| CA2458121A1 (en) | 2003-03-06 |
| BR0212043A (pt) | 2004-08-17 |
| ZA200401375B (en) | 2004-11-17 |
| SA02230268B1 (ar) | 2007-02-17 |
| CN1571665A (zh) | 2005-01-26 |
| PL368615A1 (en) | 2005-04-04 |
| MXPA04001552A (es) | 2004-05-17 |
| RU2301805C2 (ru) | 2007-06-27 |
| NZ531261A (en) | 2005-09-30 |
| AU2002321520B2 (en) | 2008-06-12 |
| JP2005506976A (ja) | 2005-03-10 |
| WO2003017995A1 (en) | 2003-03-06 |
| IL160455A0 (en) | 2004-07-25 |
| RU2004108466A (ru) | 2005-09-20 |
| CN101328157A (zh) | 2008-12-24 |
| KR20040030164A (ko) | 2004-04-08 |
| AR037497A1 (es) | 2004-11-17 |
| US20070208032A1 (en) | 2007-09-06 |
| CO5560539A2 (es) | 2005-09-30 |
| EP1425003A1 (en) | 2004-06-09 |
| US20050026931A1 (en) | 2005-02-03 |
| HUP0401149A2 (hu) | 2004-12-28 |
| GB0120471D0 (en) | 2001-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL153508A0 (en) | 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity | |
| IL160081A0 (en) | Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity | |
| DE60220778D1 (en) | 3,4-disubstituierte cyclobuten-1,2-dione als cxc-chemokinrezeptorliganden | |
| EP1565443A4 (en) | ACETYL 2-HYDROXY-1,3-DIAMINOALKANE | |
| DE60206736D1 (en) | 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinon-derivative als protein-kinase inhibitoren | |
| CY2014041I1 (el) | 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια | |
| ZA200302553B (en) | Arrangement of radial bogie. | |
| EP1393657A4 (en) | SEAT | |
| IL161990A0 (en) | Cetylene derivatives having mglur 5antagonistic activity | |
| EP1426065A4 (en) | PHOTO CATALYSIS DEODORANT | |
| TW516409U (en) | Chair for drumming | |
| WO2002073196A3 (en) | Individualization of therapy with antipsychotics | |
| IS6285A (is) | Setnar N-fenýl 2-hýdroxý-2-metýl-3,3,3-tríflúorprópamíð afleiður sem auka pýruvat vetnissviftis virkni | |
| GB0130802D0 (en) | Description generation | |
| TWI315216B (en) | Improved catalyst for the manufacture of acrylonitrile | |
| WO2002073206A3 (en) | Metabolic phenotyping in therapy with anxiolytics | |
| IL160944A0 (en) | Neurotensin active 2,3-diaryl-pyrazolidine derivatives | |
| GR1004664B (en) | The charakteristics and advantages of our invention are illustrated by the following description, methods and results of our research, attached figures and supporting references | |
| WO2002088714A3 (en) | Individualization of therapy with antineoplastic agents | |
| IL160455A0 (en) | Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity | |
| WO2002093162A3 (en) | Individualization of therapy with antibiotic agents | |
| AU2003256475A8 (en) | Wide dynamic range operational amplifier | |
| PL375417A1 (en) | 2,3-dihydro-isoindol-1-ones with mao-b inhibiting activity | |
| GB0122373D0 (en) | The new musical keyboard | |
| IS7131A (is) | Nýjar 2,4-díamínóþíasól afleiður |